Related Experiment Video
Updated: May 26, 2026
07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Advancing vaccinology in India.
1Department of Global Health and Population, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA, USA. jobrien@hsph.harvard.edu
Expert Review of Vaccines
|December 14, 2011
Summary
India
Area of Science:
- Public Health and Epidemiology
- Vaccinology and Immunology
Background:
- India's national immunization program requires advanced expertise in vaccinology.
- A need exists for specialized training for healthcare professionals in vaccine management and safety.
Purpose of the Study:
- To establish and deliver India's first Advanced Vaccinology Course.
- To enhance the skills of Expanded Program on Immunization (EPI) managers and physicians in vaccinology.
- To support the safe growth and management of India's national immunization program.
Main Methods:
- A comprehensive course was developed and delivered.
- Training included core lectures on epidemiology, disease surveillance, vaccine safety, and regulation.
- Interactive sessions and specialized lectures complemented the core curriculum.
Main Results:
- Approximately 55 participants, including EPI managers and physicians, attended the course.
- The course covered vaccination trends, challenges, and innovations relevant to India.
- Participants received advanced education in key vaccinology areas.
Conclusions:
- The inaugural Advanced Vaccinology Course successfully provided essential training.
- India is better equipped with skilled professionals to manage and expand its national immunization program.
- Enhanced capacity in vaccinology is crucial for public health initiatives in India.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:51Vaccinations
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...